ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 919

Sedentary Time, Physical Activity, and Concurrent Blood Pressure in Osteoarthritis Initiative Participants

Min-Woong Sohn1, Rowland W. Chang2, Grace Ahn3, Linda S. Ehrlich-Jones4, Marc C. Hochberg5, Jungwha Lee6, Michael C. Nevitt7, Pamela A. Semanik8, Jing Song6, Kai Sun9 and Dorothy D. Dunlop2, 1Institute for Public Health and Medicine, Northwestern University, Chicago, IL, 2Northwestern University Feinberg School of Medicine, Chicago, IL, 3Rheumatology, Northwestern University, Chicago, IL, 4Research CROR, Rehabilitation Institute Chicago, Chicago, IL, 5Department of Medicine, University of Maryland, Baltimore, MD, 6Northwestern University, Chicago, IL, 7Epidemiology & Biostatistics, UCSF (University of California, San Francisco), San Francisco, CA, 8Northwestern University, IL, 9Medicine, Northwestern University, Feinberg School of Medicine, Chicago, IL

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Epidemiology and Health Services Research: Epidemiology and Outcomes of Rheumatic Disease II

Session Type: Abstract Submissions (ACR)

Background/Purpose:

The inactivity physiology hypothesis suggests that sedentarism is a cardiovascular risk factor independent of time spent in moderate-vigorous activity (MV). Previous research suggests that sedentary time may be associated with increased blood pressure. But research findings to date are mixed.

Methods:

The Osteoarthritis Initiative accelerometer ancillary study includes 1760 with objective measures of physical activity, sedentary time, and blood pressure at the 48 month exam. Participants were classified into four quartile groups according to accelerometer measures of the percentage of wear time that was sedentary (<100 activity counts per minute).  Systolic and diastolic blood pressures (SBP and DBP) were modeled as a function of sedentary quartiles, demographic factors (age, gender, race, income), health behaviors (average daily MV minutes, alcohol use) and general health (osteoarthritis status,  Charlson comorbidity score, BMI, NSAID and antihypertensive medication use during the month preceding the 48–month visit).

Results:

Of 1,760 adults, 60% had knee OA, 42% used ≥1 antihypertensive medications within 30 days prior to the 48 month visit, and 24.4% had elevated BP (≥ 140/90 or 130/80 for diabetic or renal patients). BP values (see Table) show lowest SBP in the least sedentary group, while DBP is similar across all groups.  Adjusted analyses found the least sedentary group on average had SBP 1.82 mm Hg lower (95% CI, 0.04 – 3.59) than the other combined groups. Also, SBP was significantly elevated in adults with OA (2.3 mm Hg), blacks (5.7 mm Hg), and obesity (3.3 mm Hg).  But time spent in MV activity, NSAID use, and alcohol use were not associated with SBP.  The effect of sedentary time on SBP was primarily observed among adults not taking antihypertensive medications. Sedentary and MV activity were not associated with DBP in adjusted analyses. 

Conclusion:

Objectively measured sedentary time was significantly associated with increased SBP, while MV activity was not, in the model adjusted for all covariates. This finding supports the inactivity physiology hypothesis that, independent of MV physical activity, sedentary time is associated with deleterious effect on cardiovascular risk. This is the first study to test this hypothesis using objectively measured sedentary time and simultaneously controlling for antihypertensive medication use.

 

Relationship of Sedentary Behavior to Blood Pressure

Blood Pressure (mm Hg)

Quartile of Sedentary Behavior

 

Quartile 1 (Least Sedentary)

Quartile 2

Quartile 3

Quartile 4 (Most Sedentary)

 

Unadjusted Analysis

Systolic, mean (SD)

122.0 (15.8)

124.9 (16.9)

124.2 (15.9)

126.4 (16.5)

 

Diastolic, mean (SD)

74.5 (10.1)

75.4 (9.8)

74.5 (9.8)

73.8 (10.7)

 

Multiple Regression Analysis

Systolic, Adjusted* Mean Difference (95% CI)

Reference

2.44

(0.37 – 4.51)

1.03

(-1.12 – 3.17)

1.83

(-0.48 – 4.14)

p = 0.045**

Diastolic, Adjusted* Mean Difference (95% CI)

Reference

1.23

(-0.05 – 2.50)

0.42

(-0.90 – 1.73)

0.29

(-1.12 – 1.71)

p = 0.187**

 * Adjusted for demographic factors (age, gender, race,  income), health behaviors (average daily MV minutes, alcohol use) and general health (osteoarthritis status,  Charlson comorbidity score, BMI, NSAID and antihypertensive medication use during the month preceding the 48–month visit).

** Least sedentary Quartile 1 versus more sedentary Quartiles 2-4


Disclosure:

M. W. Sohn,
None;

R. W. Chang,
None;

G. Ahn,
None;

L. S. Ehrlich-Jones,
None;

M. C. Hochberg,

Abbott Laboratories, Astra-Zeneca, Bioiberica S.A., Eli Lilly Inc., Genentech/Roche, Merck Inc., Novartis Pharma A.G., Pfizer Inc., Stryker LLC, Xoma.,

5;

J. Lee,
None;

M. C. Nevitt,
None;

P. A. Semanik,
None;

J. Song,
None;

K. Sun,
None;

D. D. Dunlop,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sedentary-time-physical-activity-and-concurrent-blood-pressure-in-osteoarthritis-initiative-participants/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology